MedPath
HSA Product

SYMBICORT TURBUHALER 160/4.5 mcg/dose

Product approved by Health Sciences Authority (SG)

Basic Information

SYMBICORT TURBUHALER 160/4.5 mcg/dose

POWDER, METERED

Regulatory Information

SIN11681P

September 24, 2001

Prescription Only

Therapeutic

RESPIRATORY (INHALATION)

August 10, 2023

May 30, 2025

XR03AK07

Company Information

ASTRAZENECA AB

ASTRAZENECA SINGAPORE PTE LTD

ASTRAZENECA SINGAPORE PTE LTD

Active Ingredients

BUDESONIDE

Strength: 160 mcg/dose

FORMOTEROL FUMARATE DIHYDRATE

Strength: 4.5 mcg/dose

Detailed Information

Contraindications

**4.3 Contraindications** Hypersensitivity (allergy) to budesonide, formoterol or lactose (which contains small amounts of milk proteins).

Indication Information

**4.1 Therapeutic indications** ![Symbicort Turbuhaler Indications Table 1](https://cdn.medpath.com/drug/indication/20240520/a044ad8bed9e582df712cb64fdf569b4.png)

© Copyright 2025. All Rights Reserved by MedPath